Elaine Kingwell
Elaine Kingwell
Verified email at mail.ubc.ca
Cited by
Cited by
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
E Kingwell, JJ Marriott, N Jetté, T Pringsheim, N Makhani, SA Morrow, ...
BMC neurology 13 (1), 128, 2013
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis
A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell, ML Van Der Kop, ...
Jama 308 (3), 247-256, 2012
Incidence and prevalence of multiple sclerosis in the Americas: a systematic review
C Evans, SG Beland, S Kulaga, C Wolfson, E Kingwell, J Marriott, M Koch, ...
Neuroepidemiology 40 (3), 195-210, 2013
The natural history of secondary progressive multiple sclerosis
M Koch, E Kingwell, P Rieckmann, H Tremlett
Journal of Neurology, Neurosurgery & Psychiatry 81 (9), 1039-1043, 2010
The natural history of primary progressive multiple sclerosis
M Koch, E Kingwell, P Rieckmann, H Tremlett
Neurology 73 (23), 1996-2002, 2009
Physical activity, body mass index and bone mineral density—associations in a prospective population-based cohort of women and men: The Canadian Multicentre Osteoporosis Study …
L Langsetmo, CL Hitchcock, EJ Kingwell, KS Davison, C Berger, ...
Bone 50 (1), 401-408, 2012
Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada
E Kingwell, M Van der Kop, Y Zhao, A Shirani, F Zhu, J Oger, H Tremlett
J Neurol Neurosurg Psychiatry 83 (1), 61-66, 2012
High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991–2010)
E Kingwell, F Zhu, RA Marrie, JD Fisk, C Wolfson, S Warren, ...
Journal of neurology 262 (10), 2352-2363, 2015
Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS
E Kingwell, M Koch, B Leung, S Isserow, J Geddes, P Rieckmann, ...
Neurology 74 (22), 1822-1826, 2010
Cancer risk in multiple sclerosis: findings from British Columbia, Canada
E Kingwell, C Bajdik, N Phillips, F Zhu, J Oger, S Hashimoto, H Tremlett
Brain 135 (10), 2973-2979, 2012
Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study
JMA Wijnands, E Kingwell, F Zhu, Y Zhao, T Högg, K Stadnyk, O Ekuma, ...
The Lancet Neurology 16 (6), 445-451, 2017
Language and behavior in children with Sotos syndrome
JAK Finegan, TRP Cole, E Kingwell, ML Smith, M Smith, G Sitarenios
Journal of the American Academy of Child & Adolescent Psychiatry 33 (9 …, 1994
Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975–2009)
A Shirani, Y Zhao, E Kingwell, P Rieckmann, H Tremlett
Multiple Sclerosis Journal 18 (4), 442-450, 2012
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis
T Zhang, H Tremlett, S Leung, F Zhu, E Kingwell, JD Fisk, V Bhan, ...
Neurology 86 (14), 1287-1295, 2016
Age related multiple sclerosis severity score: disability ranked by age
A Manouchehrinia, H Westerlind, E Kingwell, F Zhu, R Carruthers, ...
Multiple Sclerosis Journal 23 (14), 1938-1946, 2017
Adherence and persistence to drug therapies for multiple sclerosis: a population-based study
C Evans, RA Marrie, F Zhu, S Leung, X Lu, DY Melesse, E Kingwell, ...
Multiple sclerosis and related disorders 8, 78-85, 2016
Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort
ME Karim, P Gustafson, J Petkau, Y Zhao, A Shirani, E Kingwell, C Evans, ...
American journal of epidemiology 180 (2), 160-171, 2014
Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts
E Kingwell, AL Leung, E Roger, P Duquette, P Rieckmann, H Tremlett
Journal of the neurological sciences 292 (1-2), 57-62, 2010
Long-term persistence with the immunomodulatory drugs for multiple sclerosis: a retrospective database study
C Evans, J Tam, E Kingwell, J Oger, H Tremlett
Clinical therapeutics 34 (2), 341-350, 2012
Evaluating the safety of β-interferons in MS: A series of nested case-control studies
HJI De Jong, E Kingwell, A Shirani, JWC Tervaert, R Hupperts, Y Zhao, ...
Neurology 88 (24), 2310-2320, 2017
The system can't perform the operation now. Try again later.
Articles 1–20